Design of Biologically Active Heparan Sulfate and Heparin Using an Enzyme‐Based Approach

No abstract is available for this paper.

• Publication year

  2009

• Venue

  ChemInform

• Publication date

  2009-08-25

• Fields of study

  Biology, Chemistry

• Identifiers
  DOI 10.1002/CHIN.200934229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Design of biologically active heparan sulfate and heparin using an enzyme-based approach.

  2009cited by this paper

• Glycosaminoglycans in Neurodegenerative Diseases.

  2021cites this paper
• The Science and Regulations of Naturally Derived Complex Drugs

  2019cites this paper
• Establishing a synergetic carbon utilization mechanism for non-catabolic use of glucose in microbial synthesis of trehalose.

  2017cites this paper
• Physiological, Pharmacological and Clinical Factors Associated with Thrombosis in Pediatric Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass

  2015influential citation
• De novo synthesis of a narrow size distribution low-molecular-weight heparin.

  2014cites this paper
• Microscale separation of heparosan, heparan sulfate, and heparin.

  2013cites this paper
• Chemoenzymatic synthesis of heparan sulfate and heparin

  2012cites this paper
• Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate.

  2012cites this paper
• Deciphering Mode of Action of Heparanase Using Structurally Defined Oligosaccharides*

  2012cites this paper
• Defining the Structural Cues within Heparan Sulfate that Direct Heparanase Cleavage

  2012cites this paper
• Heparin-derived heparan sulfate mimics that modulate inflammation and cancer

  2011cites this paper
• Enzymatic placement of 6-O-sulfo groups in heparan sulfate.

  2011cites this paper